Venmax Drugs Reports Q1 2025 Profit Growth of 77.82 Crores INR

Venmax Drugs and Pharmaceuticals Ltd. has reported a significant increase in profit for the quarter ended June 30, 2025. The company's profit before exceptional items and tax stands at 3.74 Crores INR, while the profit for the period from continuing operations is 77.82 Crores INR. The revenue from operations is 121.03 Crores INR. The company's total revenue stands at 139.89 Crores INR. The financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors.